Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Sep 7, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Sep 6, 2023 | Horse | Quarter Horse | Pergolide Mesylate | Recumbency; Seizure NOS; Oedema of the extremities (see also other SOCs for m... | Recovered/Normal |
| Sep 6, 2023 | Horse | Arab | Flunixin Meglumine Injectable | Uveitis | Ongoing |
| Sep 6, 2023 | Horse | Quarter Horse | Fenbendazol Oral Paste | Not drinking; Not eating; Diarrhoea; Colitis; Leucopenia NOS | Ongoing |
| Sep 5, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Sep 5, 2023 | Horse | Morgan | Ceftiofur Crystalline Free Acid | Uveitis | Outcome Unknown |
| Sep 2, 2023 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Death | Died |
| Sep 1, 2023 | Horse | Horse (unknown) | Firocoxib | Diarrhoea | Outcome Unknown |
| Sep 1, 2023 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Sep 1, 2023 | Horse | Horse (unknown), Arab | Polysulfated Glycosaminoglycan | Distress; Itching | Recovered/Normal |
| Sep 1, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Weight loss; Elevated triglyceride; Elevated cholesterol (total); Hyperglycae... | Outcome Unknown |
| Aug 30, 2023 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Aug 29, 2023 | Horse | Crossbred Equine/horse, Pur... | Vit E/ Selenite Inj Solution | Distress; Trembling; Increased sweating; Ataxia; Injection site swelling; Tac... | Ongoing |
| Aug 29, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 29, 2023 | Horse | Warmblood - Belgian | Pentosan Polysulfate Sodium | Injection site hair change | Outcome Unknown |
| Aug 29, 2023 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site pain; Stiffness NOS; Abnormal ultraso... | Outcome Unknown |
| Aug 28, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 28, 2023 | Horse | Horse (unknown) | Xylazine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Aug 28, 2023 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Wheezing; Pneumonia; Death by euthanasia | Euthanized |
| Aug 27, 2023 | Horse | Warmblood (unspecified) | Flunixin Meglumine Injectable | Cough | Recovered/Normal |
| Aug 26, 2023 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site lump; Injection site oedema | Recovered/Normal |
| Aug 25, 2023 | Horse | Horse (unknown) | Xylazine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Aug 25, 2023 | Horse | Warmblood (unspecified) | Flunixin Meglumine Injectable | Other abnormal test result NOS | Outcome Unknown |
| Aug 25, 2023 | Horse | Pony (unspecified) | Pergolide Mesylate | Penile erection; Penile protrusion | Outcome Unknown |
| Aug 24, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 22, 2023 | Horse | Morgan | Clenbuterol Hydrochloride | Lack of efficacy - NOS | Ongoing |
| Aug 22, 2023 | Horse | Morgan | Ciclesonide | Lack of efficacy - NOS | Ongoing |
| Aug 22, 2023 | Horse | Paint | Flunixin Meglumine Injectable | Seizure NOS; Collapse (see also Cardio-vascular and Systemic disorders); Tire... | Recovered/Normal |
| Aug 21, 2023 | Horse | Warmblood - Dutch, Oldenbur... | Pentosan Polysulfate Sodium | Injection site reaction NOS; Hair coat discolouration; Hair loss NOS; Flaking... | Ongoing; Outcome Unknown |
| Aug 21, 2023 | Horse | Quarter Horse | Praziquantel;Moxidectin | Fever | Recovered/Normal |
| Aug 21, 2023 | Horse | Quarter Horse | Altrenogest Oily Solution | Mammary gland oedema; Mammary gland disorder NOS; Localised pain NOS (see oth... | Ongoing |
| Aug 20, 2023 | Horse | Quarter Horse | Praziquantel;Moxidectin | Hives (see also Skin); Anaphylactic-type reaction | Recovered/Normal |
| Aug 18, 2023 | Horse | Welsh Pony | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 18, 2023 | Horse | Friesian | Butorphanol Tartrate | Fever; Local swelling (not application site) | Recovered/Normal |
| Aug 18, 2023 | Horse | Unknown | Xylazine | Lack of efficacy - NOS | Recovered/Normal |
| Aug 18, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Aug 17, 2023 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site bleeding; Hives (see also Skin); Lateral recumbency; Discomfor... | Recovered/Normal |
| Aug 15, 2023 | Horse | Saddlebred - American, Sadd... | Pentosan Polysulfate Sodium | Injection site nodule | Recovered/Normal |
| Aug 15, 2023 | Horse | Thoroughbred | Pentosan Polysulfate Sodium | Injection site swelling; Reluctant to move | Outcome Unknown |
| Aug 14, 2023 | Horse | Horse (unknown) | Xylazine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Aug 14, 2023 | Horse | Horse (unknown) | Xylazine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Aug 14, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 10, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Polyuria; Increased sweating; Hair shedding; Polydipsia | Outcome Unknown |
| Aug 10, 2023 | Horse | Horse (other) | Flunixin Meglumine Injectable | Fever; Lying down; Recumbency; Difficulty standing; Death by euthanasia; Absc... | Euthanized |
| Aug 10, 2023 | Horse | Quarter Horse | Diclofenac Sodium | Licking at application site | Recovered/Normal |
| Aug 9, 2023 | Horse | Mustang | Panacur | Lack of efficacy (endoparasite) - strongylids | Outcome Unknown |
| Aug 9, 2023 | Horse | Mustang | Oxybendazole | Lack of efficacy (endoparasite) - strongylids | Outcome Unknown |
| Aug 9, 2023 | Horse | Paint | Panacur | Lack of efficacy (endoparasite) - strongylids | Outcome Unknown |
| Aug 8, 2023 | Horse | Quarter Horse | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Ongoing |
| Aug 7, 2023 | Horse | Quarter Horse, Horse (unknown) | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site abscess | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.